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(CSF-cNs) are produced during the
gliogenic phase of spinal cord
development. Di Bella et al. demonstrate
that, in amniotes, CSF-cNs arise from late
Ascl1-expressing cells, and this
transcription factor controls their
development at the expense of
ependymal cells. Thus, Ascl1 confers
neurogenic potential to late spinal
progenitors.
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Generation of neuronal types at the right time, loca-
tion, and number is essential for building a functional
nervous system. Significant progress has been
reached in understanding the mechanisms that
govern neuronal diversity. Cerebrospinal fluid-
contacting neurons (CSF-cNs), an intriguing spinal
cord central canal population, are produced during
advanced developmental stages, simultaneous
with glial and ependymal cells. It is unknown how
CSF-cNs are specified after the neurogenesis-to-
gliogenesis switch. Here, we identify delayed Ascl1
expression in mouse spinal progenitors during the
gliogenic phase as key in CSF-cN differentiation.
With fate mappings and time-controlled deletions,
we demonstrate that CSF-cNs derive from Ascl1-ex-
pressing cells and that Ascl1 triggers late neurogen-
esis in the amniote spinal cord. Ascl1 abrogation
transforms prospective CSF-cN progenitors into
ependymocytes. These results demonstrate that
late spinal progenitors have the potential to
produce neurons and that Ascl1 initiates CSF-cN dif-
ferentiation, controlling the precise neuronal and
nonneuronal composition of the spinal central canal.
INTRODUCTION
Over the last two decades, substantial advances have been
made in deciphering the gene-regulatory programs that com-
mand neuronal diversity in the spinal cord and their organization
in functional sensory and motor circuits. During development,
distinct classes of neurons are produced from progenitors at
defined coordinates along the dorso-ventral and anterior-poste-
rior axes of the neural tube. Transcriptional networks translate
morphogen signaling into at least 14 cardinal populations of spi-
nal neurons, defined by their origin, gene expression, axon pro-
jection, and neurotransmission. These are dorsal dI1-dI6 and
dILA/B, ventral V0-V3 interneurons, and motoneurons (Jessell,2264 Cell Reports 28, 2264–2274, August 27, 2019 ª 2019 The Autho
This is an open access article under the CC BY-NC-ND license (http://2000; Briscoe and Novitch, 2008; Goulding, 2009; Lai et al.,
2016; Francius et al., 2013).
Subsequent to the neurogenic phase, which spans until
about embryonic day (E) 13 in the mouse spinal cord, the undif-
ferentiated progenitors begin to generate glial and ependymal
cells (Rowitch and Kriegstein, 2010). The neurogenesis-to-
gliogenesis sequence is accompanied by changes in gene
expression that reflect progenitor competence switch (Stolt
et al., 2003; Deneen et al., 2006; Rowitch and Kriegstein,
2010). Thus, it was considered that neurons were exclusively
generated in the early phases of neural tube development,
while later periods were assumed to only produce glial and
ependymal cells.
In opposition to this principle, we have identified neurogenic
events in the mouse spinal cord taking place during surprisingly
advanced stages, simultaneous with the production of astro-
cytes, oligodendrocytes, and ependymocytes. We have demon-
strated that late neurogenesis exclusively produces an intriguing
class of spinal cells, the cerebrospinal fluid-contacting neurons
(CSF-cNs) (Petracca et al., 2016). CSF-cNs are GABAergic neu-
rons around the central canal interspersed with ependymocytes
and tanycytes (Bruni, 1998; Marichal et al., 2012; Stoeckel et al.,
2003). They are identified by their peculiar morphology, with a
prominent dendritic extension with a wide bulb-like structure in
contact with the CSF (Vı́gh and Vigh-Teichmann, 1971, 1998;
Vı́gh et al., 1983). We have shown that CSF-cNs, which express
the transcription factors Gata2 and Gata3, do not belong to
any of the cardinal early-born populations of spinal neurons
(Petracca et al., 2016).
Despite the high conservation of CSF-cNs among chordates
and their discovery almost a century ago (Vı́gh et al., 2004), their
development, characteristics, and functions are just beginning
to be unraveled. CSF-cNs in different species selectively express
the ion channel Pkd2l1, with mechano- and chemo-sensitivity
(Djenoune et al., 2014; Huang et al., 2006; Petracca et al., 2016;
Orts-Del’Immagine et al., 2014; Ishimaru et al., 2006; Shimizu
et al., 2009). Interestingly, recent studies in lamprey and zebrafish
indicate that central canal neurons modulate swimming in
response to spinal cord bending and changes inCSF composition
or flow (Fidelin et al., 2015; Hubbard et al., 2016; Jalalvand et al.,
2016a, 2016b; Orts-Del’Immagine et al., 2016).rs.
creativecommons.org/licenses/by-nc-nd/4.0/).
The late origin of CSF-cNs seems to be particular to the
amniote spinal cord. In mice, rats, and chicks, CSF-cNs are pro-
duced only after the finalization of the neurogenic phase (Pet-
racca et al., 2016; Kútna et al., 2014). In contrast, in zebrafish
and Xenopus, CSF-cNs differentiate together with primarymoto-
neurons and simultaneously or preceding other interneurons
(Binor and Heathcote, 2001; Park et al., 2004; Yang et al.,
2010; Yeo and Chitnis, 2007). The remarkable late specification
of CSF-cNs in the mouse poses the question of which mecha-
nisms are underlying simultaneous neuronal and nonneuronal
development after the neurogenic-to-gliogenic switch of spinal
precursors.
In this study, we identify that the neuronal potential of late
ventral progenitors of the mouse spinal cord relies on the basic
helix-loop-helix (bHLH) transcription factor Ascl1. We show that
Ascl1 is expressed in progenitors that give rise to central
canal neurons. Ascl1 activity during the gliogenic period cell-
autonomously triggers neuronal differentiation and ensures
the selection of the CSF-cN identity. In addition, we provide
strong genetic evidence that Ascl1 controls neuronal versus
nonneuronal fate decisions, establishing the balance between
ependymocytes and neurons in the amniote spinal cord central
canal.
RESULTS
Ascl1 Is Expressed in Ventral Spinal Cord Progenitors
during Advanced Embryonic Stages
We hypothesized that late CSF-cN neurogenesis required
potent and dedicated transcriptional regulation. As we found
that the proneural protein Ascl1 had an expression resembling
the CSF-cN pattern, we decided to investigate further. Ascl1
begins to be expressed in the neural tube around E10 with a
robust dorsal presence (Helms et al., 2005; Kriks et al., 2005;
Wildner et al., 2006) and a spotty ventral expression, mostly
limited to the p2 domain (Figures S1A and S1C; Li et al.,
2005; Sugimori et al., 2007). At E13.5, corresponding to the
neurogenic-to-gliogenic switch, the spatial pattern of Ascl1 re-
mains largely unchanged (Figures S1AS1D). Double stainings
for Ascl1 and transcription factors with dorso-ventral restriction
(Figures 1A1D) show ventral Ascl1+ cells embedded in
Nkx6.1+ territories (Figure 1B), dorsal to Olig2 and Nkx2.2 do-
mains (Figures 1C and 1D). Few Ascl1+ cells are in the Olig2+
region (Figure 1C) and at the most ventral Nkx2.2+ p3 domain
(Figures 1B1D).
At E13.5, the dorso-ventral distribution of cells with high Ascl1
levels (Figure 1F) is strikingly similar to the positions where
Pkd2l1-expressing neurons start to appear 1 day later, at E14.5
(Figures 1E1H; Petracca et al., 2016). This correspondence
suggests a relationship betweenAscl1 and the neurogenic events
that generate CSF-cNs.
Central canal neurons are produced at two distinct dorso-
ventral regions into two subsets with specific positions around
the central canal, electrophysiological properties, morphol-
ogies, and functions (Djenoune et al., 2017; Petracca et al.,
2016; Park et al., 2004; Yang et al., 2010; Böhm et al., 2016;
Hubbard et al., 2016). In the mouse, late p2-pOL (oligodendro-
cyte progenitor domain) cells produce the CSF-cN0 subset,while the boundary between the p3 domain and the floor plate
(fp) generates CSF-cNs00 (Figure 1H; Petracca et al., 2016).
Consistent with an association between Ascl1 and both
CSF-cNs groups, we found that 97% ± 4% of Ascl1+ cells
are positive for Nkx6.1 (Figure 1I), which is present in all
CSF-cNs (Orts-Del’Immagine et al., 2014; Petracca et al.,
2016). Furthermore, we detected Ascl1 in Foxa2+ cells adja-
cent to the fp (Figure 1J).
CSF-cNs differentiate from progenitors still mitotically
active at E13 and E14 (Petracca et al., 2016). We found that
90% ± 5% of Ascl1-expressing cells incorporated BrdU
when applied at E13E13.5 (Figures 1K and 1N). Additionally,
most Ascl1+ cells are labeled with the progenitor marker Sox9
(Figures 1L and 1N) but lack neuronal bIII-tubulin (Figures 1M
and 1N).Central Canal Neurons Derive from Ascl1-Expressing
Progenitors
To determine the fate of late Ascl1-expressing cells, we per-
formed lineage tracing.Ascl1CreERmicewere usedwith tdTomato
reporter and induced with tamoxifen (Tam) at E13.75. At E14.5, in
addition to labeled dorsal astrocytes (Figure 1O; Vue et al., 2014),
ventral Tomato+ cells were at the origin locations of CSF-cNs
(Figures 1O, S1E, and S1F, arrowheads). We found Toma-
to+,Nkx6.1+ cells in the late p2-pOL (Figures S1E and S1G) and
Tomato+ cells expressing Foxa2 andNkx2.2 at the p3-fp interface
(Figures S1E, S1H, and S1I), consistent with developing CSF-
cNs0 and CSF-cNs00.
Ascl1-derived cells possess the morphology of differentiating
CSF-cNs, including their apical process (Figures 1P1Q, S1Gʹ,
and S1Iʹ). Importantly, E14.5 Tomato+ cells express Gata3
and Gata2 (Figures 1R and 1S), while at E16.5, they express
Gata2 and Pkd2l1 (Figures S1JS1L), all molecular signs of
the CSF-cN identity. In addition, the administration of three
Tam doses (E13.5E14.25) marked 76% ± 9% of Pkd2l1+ cells
at E18.5, while a single Tam induction labeled fewer cells (Fig-
ures 1T, 1U, S1M, and S1N). The incomplete labeling of CSF-
cNs is likely a consequence of its asynchronous generation
(Petracca et al., 2016). Consistently, Ascl1:GFP transgenic
mice marked the entire Pkd2l1+ population (Figures S1O and
S1P).Ascl1 Is Necessary for CSF-cN Development
Given Ascl1 expression in CSF-cN lineage, we produced Ascl1
mutants and found that their spinal cords lack Pkd2l1 expression
(Figures 2A2E). Hypomorphic Ascl1neoflox mice (Figures
S2FS2J; Andersen et al., 2014) showed fewer Ascl1HIGH cells
at E13.5, even in the absence of recombinase, matching a
reduced Pkd2l1+ population at E18.5 (Figures 2A2D and
S2AS2J). Thus, Ascl1 appears to play a fundamental role in in-
structing CSF-cN identity, and this is common to both CSF-cN0
and CSF-cN00 (Figure 2D).
Next, we found that Ascl1 cannot be replaced by Neurog2,
since Ascl1Neurog2 spinal cords lack Pkd2l1+ neurons (Figures
S2KS2N). Thus, Ascl1 is not merely promoting neurogenesis
of late spinal progenitors, but is also specifically required for
CSF-cN specification.Cell Reports 28, 2264–2274, August 27, 2019 2265
Figure 1. Ascl1 Ventral Spinal Progenitors
Give Rise to CSF-cNs
Ascl1 is expressed in the late ventral spinal cord
where CSF-cNs are produced.
(A–D) E13.5 mouse neural tube stained for Ascl1
and Pax3 (A), Nkx6.1 (B), Olig2 (C), or Nkx2.2 (D).
Arrowheads point to Ascl1+ p2-pOL cells (filled) or
p3 cells bordering the fp (empty); n = 3 embryos
each.
(E) Staining for Pkd2l1 and Nkx6.1 at E14.5, when
CSF-cNs appear.
(F–H) Histograms of dorso-ventral distribution of
484 Ascl1+ cells at E13.5 (F) and 108 Pkd2l1+
neurons at E14.5 (G) (not significantly different,
Mann-Whitney test, 6 or 7 embryos) and scheme
of the dual origin of CSF-cNs (H).
(I and J) Colocalization of Ascl1 and Nkx6.1 in the
p2 area (I) or Foxa2 in the ventral region (J).
(K–N) Ascl1+ cells are late progenitors. Staining for
Ascl1 and BrdU (12-h pulses) (K), Sox9 (L), or bIII-
tubulin (M) on E13.5 spinal cords and percentage
of positive cells (n = 340, 181, 116 cells, 2 or 3
embryos) (N).
(O–S) Late Ascl1+ progenitors give rise to CSF-
cNs. E14.5 Ascl1CreER;CAG:floxStop-tdTomato
embryos induced with Tam at E13.75 are stained
for Sox9 (O–Q), Gata3 (R), or Gata2 (S).
(R and S) Ventral Tomato cells remain in the ven-
tricular zone and express Gata3 (R) and Gata2 (S).
(T and U) Central canal of E18.5 Ascl1-
CreER;CAG:floxStop-tdTomato stained for Pkd2l1,
induced with multiple pulses (E13.5–E14.25, n =
292 cells, 4 embryos). Single induction marked
48% ± 19% of CSF-cNs (Tam at E13.75, n = 506
cells, 6 embryos; not shown).
Bars are mean ± SD. Scales are 10 mm, except
40 mm in (A)–(E) and (O).
See also Figure S1.To determine whether the absence of Pkd2l1 in Ascl1 mu-
tants truly reflects the lack of CSF-cNs, we evaluated a set
of CSF-cN markers. First, we found that bIII-tubulin+ pro-
cesses are largely absent in the Ascl1/ ependymal area (Fig-
ure 2F), contrasting with the projections into the wild-type cen-
tral canal (Orts-Del’Immagine et al., 2014; Petracca et al.,
2016; Stoeckel et al., 2003). Similarly, Gata2, Gata3, and
Pkd1l2, partner of Pkd2l1 in CSF-cNs (Petracca et al., 2016;
England et al., 2017), are undetectable in the central canal of
Ascl1 KO (Figures 2G2I). Neither Nkx6.1HIGH (Figure 2J;
Orts-Del’Immagine et al., 2014; Petracca et al., 2016) nor
Sox2+/Sox9 cells (Figure 2K) are found in the Ascl1/ central
canal, both of which are characteristic of CSF-cN. Finally, the
organized expression of Nkx6.1 and Sox2/9 around the central2266 Cell Reports 28, 2264–2274, August 27, 2019canal in Ascl1 KO mice proves that the
absence of CSF-cNs is not due to the
lack of the ependymal layer (Figures 2J
and 2K).
Furthermore, we analyzed E14.5 em-
bryos, when CSF-cNs normally start to
appear, and we rarely found Pkd2l1+,
Gata2+, or Gata3+ cells in the Ascl1mutant ventricular zone (Figures 2L2O). The absence of these
early post-mitotic markers evidences a failure at the beginning
of the CSF-cN differentiation program.
Ascl1 Triggers Neuronal Commitment of Late
Progenitors of the Mouse Spinal Cord
Even though CSF-cNs are highly conserved throughout verte-
brates (Vı́gh and Vigh-Teichmann, 1998; Vı́gh et al., 1977), only
in chickens, rats, and mice they arise late during the gliogenic
period of development. Despite this clear distinction in develop-
mental timing, CSF-cNs from different organisms share a dual
origin and express common identity genes (Djenoune et al.,
2014; Petracca et al., 2016; Yang et al., 2010; Andrzejczuk
et al., 2018).
Figure 2. Ascl1 Controls CSF-cN Differentia-
tion
(A–D) Pkd2l1+ neurons depend on Ascl1 expres-
sion. Spinal central canal from E18.5 control (A),
hypomorphic Ascl1neoflox (B), and Ascl1 KO (C)
mice. Number of total Pkd2l1+ neurons (left) or CSF-
cN0/CSF-cN00 (right) per section (n = 18–30 sections,
2–4 embryos each) (D). ***p < 0.001, letters indicate
significant differences, Kruskal-Wallis with post hoc
Dunn’s test.
(E–K) Ascl1 mutants lack CSF-cNs. Staining for
Pkd2l1 (E), bIII-tubulin (F), GFP (Gata2GFP) and
b-Gal (Gata3lacZ) (I), Nkx6.1 (J), and Sox2/9 (K), and
in situ hybridizations for Pkd1l2 (G) and Gata2 (H) in
control and Ascl1 KO E18.5 spinal cord (n = 3–6
embryos each). Arrows point to Nkx6.1high or
Sox2+/9– cells, absent in mutants.
(L–O) CSF-cNs fail to initiate differentiation in Ascl1
mutants. E14.5 spinal cords stained for Pkd2l1 and
GFP (Gata2, L) or b-Gal (Gata3, N). Positive cells
per section in the ventricular zone (arrowheads,
M and O, ***p < 0.001, Mann-Whitney test, 10–30
sections, 2 embryos each).
Bars are mean ± SD. Scale bars are 20 mm, 40 mm in
(G) and (H).
See also Figure S2.We asked whether early-born CSF-cNs in non-amniotes are
also critically controlled by Ascl1. In zebrafish, the loss or
downregulation of ascl1a or ascl1b had mild effects on the
number of CSF-cNs, while the simultaneous downregulation
of both paralogs resulted in a reduced Pkd2l1+ population,
without losing either CSF-cNs0 or CSF-cNs00 (Figure 3A,
40% reduction). Thus, in zebrafish, Ascl1 is not an absolute
requirement for CSF-cN development. This mechanism con-
trasts with their specification in the mouse (complete elimina-
tion in Ascl1 KO), where CSF-cNs arise from unique late
neurogenic events through a mechanism fully dependent on
Ascl1.Cell ReSo far, we hypothesized that the activity
of Ascl1 in late ventricular cells is crucial for
CSF-cN commitment. Nevertheless, their
absence in Ascl1/ mice might be due
to altered early neurogenesis, changes
in proliferation (Castro et al., 2011), or
modifications in patterning leading to
decreased progenitors. However, in Ascl1
mutants, we did not find alterations in
the differentiation of early V2 neurons
or motoneurons (Figures S3AS3D) or
differences in proliferation and density
of ventral progenitors at E13.5 (Figures
S3ES3I). Finally, dorso-ventral patterning
was not affected in the mutants (Figures
S3E and S3G). These experiments indicate
that the absence of Ascl1 does not result in
defects in the germinative zone that could
lead to the lack of CSF-cNs in Ascl1/
embryos.To rigorously test whether Ascl1 controls the commitment of
CSF-cN progenitors at advanced neural tube phases, we de-
signed time window Ascl1 deletions. Previous studies showed
that Foxn4 mutants lack ventral Ascl1 expression at E10E12
(Figures 3B and 3E; Li et al., 2005; Del Barrio et al., 2007).
However, we discovered that by E13.5, Ascl1 is completely
recovered in the ventral Foxn4 null neural tube (Figures 3C and
3E). Interestingly, these mutants develop Pkd2l1+ neurons nor-
mally (Figures 3D and 3E), which still depend on Ascl1 (Figures
S3JS3M). Thus, early Ascl1 is unrelated to CSF-cN differentia-
tion, suggesting that the specification of central canal neurons is
associated with Ascl1 activity at advanced developmental timeports 28, 2264–2274, August 27, 2019 2267
Figure 3. Ascl1 Controls Late Neurogenesis in the Mammalian
Ventral Spinal Cord
(A) ascl1 is not a master regulator of CSF-cN in zebrafish. pkd2l1 expres-
sion in 24 h post-fertilization (hpf) zebrafish (lateral view) wt or
ascl1a mutants ± ascl1b morpholino (MO). ascl1a loss and ascl1b down-
regulation resulted in reduced Pkd2l1+ neurons (wt 83 ± 4a, ascl1a mut
69 ± 8a,b, ascl1b-MO 71 ± 6b,c, ascl1a mut+ascl1b-MO 48 ± 10c cells;
mean ± SD; 10 embryos each), but present and organized in subsets.
Letters indicate different groups, p < 0.05, Kruskal-Wallis with post
hoc Dunn’s test.
(B–E) Early Ascl1 is dispensable for CSF-cN production. E11.5 (B)
and E13.5 (C) wt and Foxn4 KO spinal cords are stained for Ascl1;
E18.5 for Pkd2l1 (D). Ventral Ascl1+ cells per hemisection, absent in
E11.5 Foxn4/, and restored by E13.5 (E) (n = 4–10 sections, 2 embryos
each).
2268 Cell Reports 28, 2264–2274, August 27, 2019points. We generated temporally controlled conditional Ascl1
knock-outs, using the inducible CAG:CreER transgene with the
Ascl1neoflox allele. Application of Tam at E12.5 to guarantee the
elimination of Ascl1 by E13.5 (Ascl1DE12.5) resulted in the lack
of Pkd2l1 expression (Figures 3F3H), phenocopying Ascl1
mutants.
In summary, we demonstrate that in the mouse, the delayed
secondwave of Ascl1 is exclusively responsible for CSF-cN gen-
eration, while in zebrafish, the production of CSF-cNs is an early
neurogenic event, not fully dependent on Ascl1. We propose that
in a gliogenic and ependymogenic context, such as in the
mouse, Ascl1 activity is fundamental to initiate CSF-cN differen-
tiation and could then be relevant not only for CSF-cN specifica-
tion, but also to prevent the acquisition of nonneuronal fates.
Ascl1 Controls Late Neuronal versus Ependymal Fate
Decision
To better understand the role of Ascl1 during late spinal cord
development, we asked which identity is adopted by prospec-
tive CSF-cN progenitors in the absence of Ascl1. We performed
fate-mappings using Ascl1CreER and tdTomato, which, as
shown above, mark cells around the central canal, the vast
majority Pkd2l1+ neurons (Figures 1T, 1U, and S4A; 74%–
100%, low Tam dose for sparse labeling). In Ascl1 mutants,
this protocol rendered an unchanged number of Tomato+ cells
in the central canal or in the ventral spinal cord (Figures 4A, 4D,
and S4BS4D).
We first carefully examined the morphology of Tomato+
cells in the ependymal area of control and Ascl1 mutants.
As expected, red cells in controls have the features of
CSF-cNs: a round soma, a process into the central canal
lumen, and an axon extending ventrally (Figures 4B, 4C, and
S4E). In contrast, Tomato+ Ascl1/ cells possess a wider sur-
face facing the ventricle (Figures 4E4G and S4F), rarely pro-
trude into the central canal (Figure 4H), and are closer to the
ventricle than control cells (Figure S4H). The heterogeneity
of labeled cells in Ascl1 KO is similar to the morphological
diversity of spinal ependymocytes (Figure S4G; Meletis
et al., 2008; Bruni, 1998).
These features suggest that prospective CSF-cN progenitors,
which fail to acquire neuronal character in the absence of Ascl1,
adopt the morphology of central canal ependymocytes. We
further analyzed them using a battery of molecular markers.
Tomato+ cells in controls express Pkd2l1, Gata2, and bIII-
tubulin, consistent with the CSF-cN identity, while none in
Ascl1 KO were positive for these proteins (Figures 4I, 4K, and
S4IS4K). On the contrary, Ascl1/ Tomato+ cells were labeled
with antibodies against Foxj1, a ciliation transcription factor ex-
pressed after ependymal commitment and absent in murine
CSF-cNs (Figure 4J), Sox9, Nfia, Vimentin, and S100b, markers
of ependymocytes (Figures 4K and S4LS4R).(F–H) Delayed Ascl1 initiates CSF-cNs specification. Ascl1flox (F) and Ascl1-
DE12.5 (G) E18.5 spinal cords are stained for Pkd2l1 (H) (n = 60 sections,
4 embryos each).
Bars are mean ± SD. ***p < 0.001; ns, non-significant; Mann-Whitney test.
Scale bars are 40 mm in (B) and (C) and 20 mm in (D), (F), and (G).
See also Figure S3.
Figure 4. Ascl1 Switches Ependymal to Neuronal Fate of Late Spinal Cord Cells
(A–H) Prospective CSF-cN progenitors acquire ependymocyte morphology in Ascl1/. Labeled cells in E18.5 control (A–C) and Ascl1 KO (D–F) have distinct
morphologies. Inmutants, Tomato+ cells have a wider apical surface (G) and do not protrude in the canal (H). ***p < 0.0001, Mann-Whitney test and Fisher’s exact
test (n = 40–60 cells each).
(I–K) Labeledmutant cells express ependymalmarkers. Tomato+ cells expressing Gata2 (GFP; I) in control or Foxj1 (J) inmutants. Tomato+ cells (%) with CSF-cNs
or ependymal markers (K). ***p < 0.001; ns, non-significant; Fisher’s exact test. (Number of cells is indicated.)
Distinct membrane properties of labeled cells.
(L) Tomato+ cells injected with Lucifer yellow in KOs were dye-coupled with neighbors (asterisk, n = 5/7).
(M and N) Control labeled cells responded to depolarization with action potentials (25 pA, 500ms; n = 10/11), but notmutants (n = 0/12). ***p < 0.001, Fisher’s test.
(O) Mutant cells have lower resistance than controls (89 ± 52 macrophage versus 1–10 GU; n = 11–13 cells).
(P–R) Evoked currents (P) and quantifications of fast (0–2 ms, 0 mV step; Q) and slow currents (20–70 ms, 40 mV step; n = 10–13 cells; R). ***p < 0.0001,
Mann-Whitney test. Results are mean ± SEM.
(S–U) Increased number of ependymocytes inAscl1mutants (T), shown by Foxj1 staining (S), result in an elongated central canal (U). ***p < 0.0001, Mann-Whitney
test. Mean ± SD (n = 30 sections, 4 embryos each).
Scale bars are 10 mm in (A), (D), and (S) and 5 mm in (B), (E), (I), and (J). In (G), (T), and (U), lines are mean ± SD.
(V) Summary scheme showing that CSF-cNs arise from two sets of Ascl1+ late ventral progenitors in the p2/pOL domain and in the boundary of the p3 domain with
the fp. Ascl1 triggers CSF-cN development and controls neuronal versus ependymal fate.
See also Figure S4.
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To confirm this neuronal-to-ependymal fate change in Ascl1
mutants, we recorded the electrophysiological properties of
Tomato+ cells by whole-cell patch-clamp. Control Tomato+ cells
generated action potentials in response to depolarizing steps in
current-clamp (Figures 4M and 4N; Petracca et al., 2016; Mari-
chal et al., 2009), while mutant cells were unable to fire (Figures
4M and 4N). In voltage-clamp, control cells responded with
voltage-dependent, fast inward and slow outward currents,
typical of neurons (Figures 4P4R and S4S). However, Tomato+
cells in mutants showed small currents after changes in potential
(Figures 4P4R and S4S), similar to those described for ependy-
mal cells (Marichal et al., 2012). We also determined that while
control cells have a high input resistance, a trait of CSF-cNs (Fig-
ures 4O and S4T; Petracca et al., 2016), labeled mutant cells
showed strong leakage currents, typical of ependymocytes
(Figures 4O and S4T; Bruni, 1998; Marichal et al., 2012).
Finally, by including Lucifer yellow in the recording pipette, we
found that most mutant Tomato+ cells were dye-coupled with
neighboring cells (Figure 4L, asterisk), connections that were
not seen in Tomato+ cells of controls (Figure 4L) and that reflect
gap junctions between ependymal cells (Bruni, 1998; Marichal
et al., 2012).
Altogether, our morphological, molecular, and electrophysio-
logical characterization indicates that late progenitors that
normally produce CSF-cNs become ependymocytes of the cen-
tral canal when missing Ascl1. Consistent with a neuronal-to-
ependymal fate transformation, we found that the spinal cord
of perinatal Ascl1 mutants possesses an increased number of
ependymocytes in the lateral walls of the central canal (Figures
4S and 4T), resulting in an enlarged canal compared to control
spinal cords (Figure 4U).
DISCUSSION
This study demonstrates that neurogenesis during advanced
developmental stages of the mouse spinal cord selectively pro-
duces CSF-cNs and is strictly dependent on Ascl1. Ventral pro-
genitor cells with delayed Ascl1 expression generate central
canal neurons, while the rest of the ventricular zone produces
astrocytes, oligodendrocytes, and ependymocytes. We pro-
vide compelling evidence that Ascl1 is a key player in the
neuronal CSF-cN commitment of late progenitors, controlling
the proportion of neurons and nonneuronal cells lining the
central canal.
Ascl1 Triggers Late Neurogenesis in the Mouse Spinal
Cord
In amniotes, spinal central canal neurons are produced when
neurogenesis is largely suppressed and progenitors are
massively committed to glial and ependymal fates (Petracca
et al., 2016; Rowitch and Kriegstein, 2010). We show that
Ascl1 is expressed in a discrete group of late ventral progenitors
at dorso-ventral positions matching CSF-cN location and pre-
ceding CSF-cN birth. Although Ascl1 is also present earlier in
ventral p2 and p3 precursors (Li et al., 2005; Del Barrio et al.,
2007; Peng et al., 2007; Sugimori et al., 2007), our experiments
indicate that the deferred second wave of Ascl1 is independent
of early V2-related Ascl1 expression and linked to the differenti-2270 Cell Reports 28, 2264–2274, August 27, 2019ation of CSF-cNs. First, the proper generation of CSF-cNs in
Foxn4mutants takes place despite the absence of the first round
of Ascl1 expression. Second, genetic labeling of the second
wave of Ascl1 expression (E13.5E14.5) specifically marks
central canal neurons. Third, time-controlled deletion of Ascl1
during late stages abrogates CSF-cN neurogenesis.
Our experiments show that Ascl1 mutant mice are devoid of
CSF-cNs, in an expression level-dependent manner. Thus,
high levels of Ascl1 activate neurogenesis during the gliogenic
phase of the neural tube and initiate CSF-cN specification pro-
grams. These findings are in line with Ascl1 being a central player
in neuronal commitment (Casarosa et al., 1999; Castro et al.,
2011; Raposo et al., 2015) and its role in assigning specific
neuronal identities (Parras et al., 2002; Wildner et al., 2006;
Helms et al., 2005; Pattyn et al., 2004; Borromeo et al., 2014).
Ascl1 Restricts Ependymal Fate in Prospective CSF-cN
Progenitors
Central canal neurons develop from ventral domains that also
give rise to vA2-vA3 astrocytes (Hochstim et al., 2008; Tsai
et al., 2012), oligodendrocytes (Zhou and Anderson, 2002; Lu
et al., 2002), and ependymocytes (Yu et al., 2013; Fu et al.,
2003). Our fate mappings show that when neurogenesis is
impaired by Ascl1 absence, CSF-cN precursors are converted
into ependymal cells lining the central canal. Transfated cells
appear to be indistinguishable from non-labeled ependymo-
cytes, with mural apical surface, gap junctions, selective
markers, and characteristic membrane properties (Alfaro-
Cervello et al., 2012; Bruni, 1998; Marichal et al., 2009).
These results strongly suggest that CSF-cNs are produced
from progenitors with cryptic bipotency to generate neurons
and ependymal cells and that Ascl1 triggers neuronal commit-
ment. We propose that Ascl1 is crucial to suppress the
dedicated program that converts the remaining ventricular cells
into ependymocytes (Shimada et al., 2017; Jacquet et al., 2009;
Kyrousi et al., 2015).
The role of Ascl1 in CSF-cN differentiation seems unusual
compared to the majority of Ascl1 functions, involved in binary
decisions between neuronal subtypes (Casarosa et al., 1999;
Mizuguchi et al., 2006; Wildner et al., 2006). Interestingly, in the
late spinal cord, Ascl1 switches between simultaneously pro-
duced neuronal and nonneuronal fates. This is reminiscent of
the role of Ascl1 in Schwann cell precursors, where it drives
parasympathetic neurons instead of glial differentiation (Dya-
chuk et al., 2014). Altogether, this proves the extraordinary ca-
pacity of Ascl1 to initiate neurogenesis even after commitment
toward glial or ependymal fates, and it is consistent with the
use of Ascl1 in forced neuronal transformations (Arlotta and Ber-
ninger, 2014; Karow et al., 2012; Vierbuchen et al., 2010).
Ascl1 Requirement for CSF-cN Differentiation in
Amniotes versus Non-amniotes
Among vertebrate species, there are striking differences in the
timing of central canal neurons. In amniotes, such as mice,
rats, and chickens, CSF-cNs are produced at advanced stages
during the gliogenic phase (Petracca et al., 2016; Kútna et al.,
2014) and after interneurons and motoneurons (Rowitch and
Kriegstein, 2010). In opposition, non-amniotic vertebrates, like
zebrafish and Xenopus, generate CSF-cNs during early develop-
ment, before or along with the rest of the spinal neurons (Binor
and Heathcote, 2001; Shin et al., 2007; Dale et al., 1987b; Yeo
and Chitnis, 2007; Huang et al., 2012; Yang et al., 2010; Andr-
zejczuk et al., 2018). Studies in the lamprey strongly suggest
that CSF-cNs are born early during the embryonic and prolarval
stages (Meléndez-Ferro et al., 2003). Given that lamprey repre-
sents the most ancient group of vertebrates, this heterochrony
suggests a post-displacement in the genesis of CSF-cNs in
amniotes, relative to the common ancestor (Smith, 2003; McKin-
ney and McNamara, 1991), and may reflect morphogenetic,
physical, or phyletic constraints or changes in the selection pres-
sures associated with the role of CSF-cNs in larval swimming
(Smith, 2003; Fidelin et al., 2015).
Despite ascl1 being involved in zebrafish early-born CSF-cN
development, it is not the main regulator, as they are still pro-
duced upon ascl1 downregulation. The partial reduction of
CSF-cN in ascl1-deficient zebrafish is markedly different to the
complete loss in mouse Ascl1 KOs. The decrease observed in
zebrafish might result from altered notch signaling influencing
CSF-cN genesis (Shin et al., 2007; Huang et al., 2012), while
their differentiation relies on bHLH proteins of the Tal family
(Yang et al., 2010; Andrzejczuk et al., 2018). We propose that
concurrently with the delay in the developmental timing of cen-
tral canal neurons along vertebrate evolution, Ascl1 was re-pur-
posed in the gene network that drives late CSF-cN production in
amniotes when progenitors are broadly committed to nonneuro-
nal cells.
The Development of Two Subpopulations of CSF-cNs
It is interesting that two distinct lineages, from non-neighboring
progenitor regions, converge to produce central canal neurons.
The dual source of CSF-cN0 (p2 and pOL) and CSF-cN00
(p3 bordering the fp) contrasts with all other classes of spinal
neurons, where subtypes are ontogenetically related and arise
from common progenitors (Stam et al., 2012; Bikoff et al.,
2016; Goulding, 2009; Delile et al., 2019; Hayashi et al., 2018).
Regardless of their domain of origin—either p2-pOL or the tip
of p3—the differentiation of central canal neurons in the mouse
converge on the activation of Ascl1 to initiate the specification
of both clusters (Figure 4V).
The double origin could be crucial for their extended dorso-
ventral distribution and/or the production of functionally distinct
subtypes. Studies in zebrafish and lamprey begin to uncover
CSF-cNs’ functions and suggest that they constitute a local
sensory motor loop to modulate posture during rapid move-
ment (Fidelin et al., 2015; Hubbard et al., 2016; Böhm et al.,
2016; Jalalvand et al., 2016a, 2016b). These studies also
exposed that dorsal and ventral CSF-cNs differ in neuromodu-
lators, apical and axonal extensions, and intraspinal postsyn-
aptic targets (Böhm et al., 2016; Hubbard et al., 2016; Djenoune
et al., 2017). Additionally, CSF-cNs0 respond to horizontal
bending, whereas CSF-cNs00 appear to react to longitudinal
larval contractions.
In the mouse, CSF-cN0 and CSF-cN00 also have morphological
differences and distinctive properties (Petracca et al., 2016),
suggesting central canal neurons with separate developmental
origins are distinct subtypes that might play specific functionsin spinal circuits. While mechanical feedback from spinal
bending can provide important information during swimming,
the role of central canal neurons in mammals is intriguing. Their
presence in every chordate species studied (Vı́gh et al., 1977,
1983, 2004; Dale et al., 1987a; Barber et al., 1982; Jalalvand
et al., 2014; Djenoune et al., 2014) suggests conserved func-
tions. Nevertheless, to what extent bending activation of CSF-
cNs plays a role in walking, and whether CSF-cNs respond
exclusively to other sensing modalities, remains to be
investigated.
In summary, we identified that the transcription factor Ascl1 is
key in promoting neuron production after the neurogenic-to-glio-
genic switch in the mouse spinal cord. Understanding cell fate
mechanisms of late multipotential spinal precursors will be
important to manipulate neuronal, glial, or ependymal choices
in repair strategies through the reactivation of developmental
programs. This study demonstrates that Ascl1 is at the top of
the CSF-cN differentiation program, triggering neuronal commit-
ment of cells also capable of producing ependymocytes (Fig-
ure 4V). The identification of Ascl1 is an important step in
understanding how the intriguing CSF-cNs are specified, and
how the neuronal and nonneuronal composition of the central
canal is properly balanced.STAR+METHODS
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Mouse Anti-Nkx6.1 DSHB Cat# F55A10; RRID: AB_532378
Mouse Anti-Pax6 DSHB Cat# Pax6; RRID: AB_528427
Mouse Anti-Lhx3 DSHB Cat# 67.4E12; RRID: AB_2135805
Mouse Anti-Isl1/2 DSHB Cat# 40.2D6; RRID: AB_528315
Mouse Anti-Ascl1 BD Pharmigen Cat# 556604; RRID: AB_396479
Rabbit Anti-Ascl1 Babco N/A
Guinea pig Anti-Gata2 Peng et al., 2007 N/A
Mouse Anti-Gata3 Santa Cruz Cat# SC-268; RRID: AB_2108591
Rabbit Anti-PKD2L1 Huang et al., 2006 N/A
Goat Anti-Sox2 Santa Cruz Cat# SC-17320; RRID: AB_2286684
Goat Anti-Sox9 R&D Systems Cat# AF3075; RRID: AB_2194160
Mouse Anti-bIII-tubulin Covance Cat# MMS435P; RRID: AB_2313773
Rabbit Anti-Hb9 Sam Pfaff, Salk Institute, CA, USA. N/A
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Mouse Anti-FoxA2 Abcam Cat# ab117542; RRID: AB_10938341
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Rabbit Anti-dsRed Clontech Cat# 632496; RRID: AB_10013483
Guinea pig Anti-Chx10 Sam Pfaff, Salk Institute, CA, USA. N/A
Rat Anti-bGal Martyn Goulding, Salk Institute, CA, USA N/A
Rat Anti-Pax3 Martyn Goulding, Salk Institute, CA, USA N/A
Rat Anti-BrdU Immunodirect Cat# MCA2060T; RRID: AB_566394
Rabbit Anti-Nfia Active motif Cat#39397; RRID: AB_2314931
Chicken Anti-Vimentin Chemicon Cat# AB5733; RRID: AB_11212377
Mouse Anti-S100b Sigma Cat# S2532; RRID: AB_477499
Mouse Anti-NeuN Chemicon Cat# A60; RRID: AB_2314889
Mouse Anti-Foxj1 eBioscience Cat#14-9965-80; RRID: AB_1548836
Secondary antibodies Jackson ImmunoResearch Laboratories (West Grove, PA) N/A
Experimental Models: Organisms/Strains
Ascl1Neo Guillemot et al., 1993 MGI ID: 1857470
Ascl1CreERT2 Kim et al., 2011 MGI ID: 4452601
Ascl1flox Pacary et al., 2011 MGI ID: 5141455
Tg Ascl1:GFP Gong et al., 2003 MGI ID: 3845062
Ascl1KiNgn2 Parras et al., 2002 MGI ID: 2388165
Gata2GFP Suzuki et al., 2006 MGI ID: 2673268
Foxn4LacZ Li et al., 2004 MGI ID: 3054789
Tg CAG:CreER Hayashi and McMahon, 2002 MGI ID: 2182767
GlastCreERT2 Mori et al., 2006 MGI ID: 3830051
Gata3LacZ van Doorninck et al., 1999 MGI ID: 2181200
Ai14 td-Tomato Madisen et al., 2010 MGI ID: 3809524
piat25215 Pogoda et al., 2006 ZFIN ZDB-ALT-040716-18
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Oligonucleotides
See Table S1 for primers used in this study N/A
Morpholino: MO-Ascl1b
TCGTAGCGACGACAGTTGCCTCCAT




Prism Graphpad Graphpad Software N/A
MATLAB Mathworks N/A
Zeiss LSM Image Browser Zeiss N/ALEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the Lead Contact, Guillermo
Lanuza (glanuza@leloir.org.ar). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All experiments were conducted according to the protocols approved by the Institutional Animal Care andUse Committee (IACUC) of
Fundación Instituto Leloir. Mouse lines used: Ascl1neo (Guillemot et al., 1993), Ascl1CreER (Kim et al., 2011), Ascl1neoflox (Pacary et al.,
2011), Ascl1:GFP (AU176, Gensat; Gong et al., 2003), Ascl1Neurog2 (Parras et al., 2002),Gata2GFP (Suzuki et al., 2006), Foxn4 (Li et al.,
2004), CAG:CreER (Hayashi and McMahon, 2002), Gata3lacZ (van Doorninck et al., 1999), GlastCreER (Mori et al., 2006) and Ai14
td-Tomato conditional reporter (Madisen et al., 2010). Mice were housed under controlled environment in a 12h light/dark cycle,
with food and water ad libitum. Time pregnancies were determined by detection of vaginal plug and midday was designated embry-
onic day (E) 0.5. Control animals were wild-type (wt) littermates or offsprings with genotypes without phenotypic effects. Gender was
not determined. Genotyping of mice was performed by PCR using allele-specific primers (see Table S1).
Zebrafish
Zebrafish experiments were done in accordance to the national animal welfare committees (LANUV Nordrhein-Westfalen) and the
University of Cologne. Zebrafish line used: piat25215 ascl1amutant (Pogoda et al., 2006). Experiments were performed in 24 hpf (hours
post-fertilization) embryos; gender was not determined.
METHOD DETAILS
Animals
Induction of CreER activity was achieved by tamoxifen (Tam) administration at the indicated stages. Dosis of Tamwere 75mg/kg b.w.
i.p. or 3 pulses of 50 mg/kg for Ascl1CreER, 150 mg/kg for CAG:CreER and 5 mg/kg for GlastCreER. Embryos were dissected in PBS
buffer. Embryos or isolated cords were fixed for 1 h in 4% paraformaldehyde (PFA in PBS) and cryoprotected in 20% sucrose (over-
night, 4C) prior to embedding in Cryoplast (Biopack). Stage-matched littermates of desired genotypes were aligned and embedded
together to ensure identical processing conditions. Tissue was cryosectioned 30 mm thick (Leica 3050S, Leica Biosystems).
Zebrafish piat25215 mutants, which have a truncated version of ascl1a, were identified by the absence of lactotropes, assessed by
in situ hybridization against prl (Pogoda et al., 2006). The antisense morpholino (MO) for ascl1b (50-TCGTAGCGACGACA
GTTGCCTCCAT-30, Gene Tools LLC) was diluted in 1x Danieu’s buffer at 0.033 pmol/nl and injected (1-1.5 nl) into embryos at the
one- to four-cell stage.
Immunohistochemistry
Antibody stainings were performed as previously described (Carcagno et al., 2014). Briefly, cryostat sections were washed in PBS
containing 0.1% Tween20 (PBST) and treated with blocking solution (5% HI-serum, 0.1% Triton X-100 in PBS) for 1h. Primary an-
tibodies at the appropriate dilutions in blocking solution were incubated overnight at 4C. After incubation, slides were washed 3
times 10 min each with PBST and incubated with Cy-labeled species-specific secondary antibodies (Jackson ImmunoResearch)
for 2-3 h. at RT. Sections were mounted with PVA-DABCO or dehydrated in ethanol/xylene series and mounted with DPX (Sigma
Aldrich). For antibody details, see ‘‘Key Resources Table.’’e2 Cell Reports 28, 2264–2274.e1–e3, August 27, 2019
In BrdU-labeling experiments, females were injected with bromodeoxyuridine (i.p. 20-50 mg/kg b.w. for multiple or single admin-
istrations, respectively). Previous to immunohistochemistry, HCl-antigen retrieval was performed.
In situ hybridization
Non-radioactive in situ hybridization in mouse sections was performed as previously described (Carcagno et al., 2014). Briefly, tissue
sections were fixed 15 min with PFA 4%, treated with proteinase K (3 mg/ml, 3 min), followed by PFA 4% 10 min and PBS washes.
Slides were incubated in triethanolamine-acetic anhydrate pH 8.0 10 min, permeabilized with Triton X-100 1% in PBS for 30 min and
washed. Sections were incubated for 2 h with hybridization solution (50% formamide, 5x SSC, 5x Denhardt, 250 mg/ml yeast tRNA).
Digoxigenin-labeled RNA probes were generated by in vitro transcription. Probes used were Pkd1l2 (Petracca et al., 2016), Gata2
and Ascl1 (Carcagno et al., 2014). Slides were blocked with 10% HI-serum in TBS 0.1% tween-20 for 2 h, incubated O.N. at 4C
with alkaline phosphatase-labeled anti-DIG antibody (Roche) and enzymatic activity was detected with BCIP and NBT. In zebrafish
embryos, single and double whole-mount in situ hybridizations were performed as described previously (Pogoda et al., 2006). Ribop-
robes used were pkd2l1 (this study) and prl (prolactin) to recognize ascl1a mutants (Pogoda et al., 2006). Brightfield pictures were
captured by digital camera on Zeiss Axioplan microscope.
Acute Spinal Cord Slice Recordings
Tissue isolation and recording were done as described before (Petracca et al., 2016). E18.5 Spinal cords were dissected in chilled
low-Calcium Ringer’s solution (in mM: 128 NaCl, 4.69 KCl, 25 NaHCO3, 1.18 KH2PO4, 3.25 MgSO4, 0.25 CaCl2, 1.3 MgCl2 and
22 glucose, saturated with 5% CO2-95%O2). Slices (400 mm thick) were cut in vibrating microtome (Leica VY1000E) and transferred
to artificial CSF (in mM: 125 NaCl, 2.5 KCl, 2 NaH2PO4, 25 NaHCO3, 2 CaCl2, 1.3 MgCl2, 1.3 Na-ascorbate, 3.1 Na-pyruvate, 10
dextrose; 315 mOsm) bubbled with 95% O2-5% CO2 at 30
C for > 1h. Following recovery, slices were transferred to a recording
chamber mounted on an Olympus BX61WI microscope at RT.
Tomato+ cells around the central canal were identified by fluorescence and infrared DIC videomicroscopy using an EM-CCD cam-
era (Hamamatsu). Whole-cell recordings were performed using microelectrodes (4-5MU) filled with (mM): 150 K-gluconate, 4 MgCl2,
0.1 EGTA, 1 NaCl, 10 HEPES, 4 ATP-tris, 0.3 GTP-tris, 10 phosphocreatine. All recordings were obtained using Axopatch 200B am-
plifiers, digitized and acquired at 20 KHz using pClamp 10 (Molecular Devices). Input resistance was obtained from current traces
evoked by a hyperpolarizing step of 10 mV. Voltage-dependent currents were recorded by applying conditioning voltage steps of
10 mV from 60 mV holding potential. Spiking responses were recorded by applying depolarizing current steps (5 pA increments;
500 ms) under current clamp, keeping the cells at 60 mV. To subtract leakage currents, we used the P/N subtraction protocol in
pClamp 10. Dye-coupled cells were visualized in living slices by injecting LuciferYellow-CH (0,1%, Molecular Probes) through the
patch pipette.
Imaging
Imageswere captured using Zeiss LSM510Meta and Zeiss LSM5 Pascal confocal microscopes using LSM Image Browser Software
(Zeiss). Micrographs were processed using Adobe Photoshop and Adobe Illustrator.
QUANTIFICATION AND STATISTICAL ANALYSIS
At least ten sections were examined from each embryo, and no less than three embryos of each genotype were used. In all exper-
iments, control animals from the same litter were used. Results are shown as mean ± SD, unless stated. Differences between groups
were evaluated by non-parametric Mann-Whitney U test, Kruskal-Wallis one-way analysis of variance with post hoc Dunn’s Multiple
Comparison test or Fisher test (GraphPad Software Inc). Results were considered statistically significant when p < 0.05 (*p < 0.05,
**p < 0,01, ***p < 0.001). Ascl1 levels were assessed using a MATLAB script (Carcagno et al., 2014) to measure intensity of individual
cells. A cell was considered Ascl1HIGH when its intensity was above 4 SD of background.
DATA AND CODE AVAILABILITY
The published article includes all datasets/codes generated or analyzed during this study.Cell Reports 28, 2264–2274.e1–e3, August 27, 2019 e3
Cell Reports, Volume 28Supplemental InformationAscl1 Balances Neuronal versus Ependymal
Fate in the Spinal Cord Central Canal
Daniela J. Di Bella, Abel L. Carcagno, M. Lucía Bartolomeu, M. Belén Pardi, Heiko






Figure S1. Related to Figure 1. 
 
Ascl1 ventral spinal cord progenitors give rise to cerebrospinal fluid-contacting 
neurons.  
 
A-D) Ascl1 expression in the developing spinal cord. In situ hybridizations (A-B) and 
immunohistochemistry (C-D) for Ascl1 on E11.5 and E13.5 spinal cord cross sections. Ascl1 is 
expressed in the dorsal ventricular zone and in a limited number of ventral cells (arrowheads). 
Dashed lines indicate the ventral limit of the dorsal domain. 
E-N) Late Ascl1+ progenitors give rise to both CSF-cN’ and CSF-cN’’. Ascl1CreER;CAG:floxStop-
tdTomato embryos were treated with tamoxifen at E13.75 (75mg/kg i.p.) and analyzed at E14.5 (E-
I), E16.5 (J-L) or E18.5 (M-N). Detection of Tomato at E14.5 together with Nkx6.1 (E,G) or Foxa2 
and Nkx2.2 (H-I) identified cells in the p2/pOL domain (E,G, filled arrowheads, CSF-cN’) and p3 
adjacent to the floor plate (E,H,I, empty arrowheads, CSF-cN”). F) Dorso-ventral position of Tomato+ 
cells (n=161, 4 embryos) analyzed together with Nkx6.1 or Nkx2.2 indicate that Ascl1-derived cells 
are clustered similarly to CSF-cN’ and CSF-cN” subsets (Petracca et al., 2016). Green bars indicate 
the dorso-ventral extension of Nkx6.1 and Nkx2.2. J-L) E16.5 Tomato+ cells with the characteristic 
morphology of CSF-cN stained against Nkx6.1 (J), Gata2 (K) or Pkd2l1 (L). M-N) Magnification of 
Ascl1-derived CSF-cNs at E18.5, stained for Tomato and Pkd2l1. Tomato is selectively expressed 
in Pkd2l1+ cells in the lateral aspects of the central canal (CSF-cN’, M) and ventral to the central 
canal (CSF-cN”, N). 
O-P) All CSF-cN derive from Ascl1+ cells. Short-term lineage tracing in the Ascl1:GFP transgenic 
line. Perinatal spinal cord sections stained against Pkd2l1 and GFP. All CSF-cNs were GFP+ 
(n=337/337 cells analyzed, 2 embryos).  







Figure S2. Related to Figure 2. 
Ascl1 controls CSF-cN differentiation. 
 
A-J) CSF-cN differentiation depends on Ascl1 expression levels. Cross sections of E18.5 spinal 
central canal (A-D) and E13.5 ventral neural tube (F-I) of control (A,F), Ascl1+/- (heterozygous, B,G), 
hypomorphic Ascl1neoflox (C,H) and Ascl1-/- (D,I) mice, stained with antibodies against Pkd2l1 (A-D) 
or Ascl1 (F-I). Quantifications of Pkd2l1+ cells per section (E, n=18-30 sections, 2-4 embryos each) 
and Ascl1HIGH cells per hemisection (J, n=6-20 sections, 1-2 embryos each) show correlation 
between the number of Ascl1+ cells at E13.5 and Pkd2l1+ neurons at E18.5. Quantification in E 
includes data in Figure 2D. 
K-N) Ascl1 is specifically required for CSF-cN differentiation. E18.5 spinal cord sections 
immunostained against Pkd2l1 in control (K), Ascl1 KO (L) or homozygous Ascl1Neurog2 (M) mice. 
The quantification of total Pkd2l1+ neurons, CSF-cN’ and CSF-cN’’ per section (N) indicates that 
Neurog2 cannot replace Ascl1 function (n=30-40 sections, 2-4 embryos each).  
Bars are mean±SD. ***p<0.001; *p<0.05; ns, non-significant; Kruskal-Wallis test followed by Dunn's 





Figure S3. Related to Figure 3. 
Ascl1 controls the late neurogenesis in the mammalian spinal cord. 
 
A-D) Lack of Ascl1 does not affect early neurogenesis in the ventral neural tube. E11.5 spinal cord 
sections of control and Ascl1 KO mice stained against Chx10 and Gata3 (A, -Gal in Gata3lacZ), 
Chx10 and Gata2 (B, GFP in Gata2GFP), and Hb9, Isl1/2 and GFP (C). The numbers of Gata2/3+ V2b 
interneurons, Chx10+ V2a interneurons or Hb9+ motoneurons (D) were not significantly changed in 
Ascl1 KO E11.5 (n=5-10 sections, 1-2 embryos each), or other stages (not shown).  
E-I) Ventricular zone patterning and proliferation is normal in Ascl1 mutants. E13.5 spinal cord 
sections from control and Ascl1 KO mice 3hs after BrdU administration (50mg/kg i.p.), stained for 
 
Nkx6.1 and BrdU (E). The number of BrdU+ cells per hemisection is unchanged (F), as well as the 
dorso-ventral extension of the Nkx6.1 (G, dotted lines in E). H) Magnifications of Nkx6.1+ cells in the 
ventricular zone of control and Ascl1 KO mice. The density of Nkx6.1+ progenitors (expressed per 
25μm ventricular opening) is similar between genotypes (I). (n=4-10 sections, 1-2 embryos each)  
J-M) Ascl1 controls CSF-cN development also in the absence of Foxn4. Pkd2l1-expressing neurons 
in E18.5 spinal cord of control (J), Foxn4 KO (K), Ascl1 KO (L) and Foxn4;Ascl1 double KO (DKO, 
M). In absence of Foxn4, Ascl1 is still required for CSF-cN development.  
Bars are mean±SD. ns, non-significant, Mann-Whitney test. Scale bars are 40μm in A-C,E, 10μm in 







Figure S4. Related to Figure 4 
Ascl1 regulates ependymal vs. neuronal fate decision in the late spinal cord 
 
A-D) Ascl1CreER faithfully identifies prospective CSF-cN progenitors. E18.5 spinal cord of 
Ascl1CreER/+;CAG:floxStop-tdTomato (control) and Ascl1CreER/-;CAG:floxStop-tdTomato (Ascl1 KO), in 
which recombination was induced by a single dose of tamoxifen at E13.75. This protocol labeled 
CSF-cNs as shown by Tomato expression in Pkd2l1+ cells. The percentage of Tomato+ cells around 
the central canal that expressed Pkd2l1 in control mice ranged between 74-100% in different 
experiments (A). Ascl1-derived cells comprise dorsal astrocytes (B, empty arrowhead), CSF-cN 
around the central canal (B, arrow) and few ventral glial cells (B, filled arrowhead). In the absence 
of Ascl1, an increased number of labeled dorsal astrocytes were found (C, empty arrowhead, Vue et 
al.,2014), but without changes in ventral cells in the parenchyma (C, filled arrowhead) or in the 
ependymal zone (B,C, arrow). Quantification of the number of Tomato+ cells in the area of the central 
canal shows no difference between control and mutant mice (D, n=10-20 sections, 3 embryos each). 
Bars are mean±SD. ns, non-significant; Mann-Whitney test. 
E-G) Examples of cellular morphologies found in control animals and mutants. The central canal (cc) 
is located on the left (dashed purple lines). In control spinal cords, Tomato+ cells display the 
appearance of CSF-cNs, with its distinctive process contacting the CSF. In the Ascl1 mutants, 
although displaying some morphological heterogeneity (F), they are part of the ventricular surface, 
with a wider apical contact and no protruding processes. The basal cellular extensions are 
extensively branched and thicker than in controls. G) Examples showing morphological 
heterogeneity of central canal ependymocytes at E18.5 labeled with GlastCreER;CAG:floxStop-
tdTomato (low dose of TAM, E12.5). H) Distribution analysis of the distance of the cell nuclei to the 
surface of the cc shows that Tomato+ cells in mutants tend to occupy positions closer to the cc, while 
in control mice, labeled CSF-cN are mostly subependymal (n=40-60 cells each).  
I-R) Prospective CSF-cN progenitors express ependymocyte markers in the absence of Ascl1. E18.5 
spinal cord sections of Ascl1CreER/+;CAG:floxStop-tdTomato (control) and Ascl1CreER/-;CAG:floxStop-
tdTomato (Ascl1 KO) induced with tamoxifen at E13.75, stained for the CSF-cN identity markers: 
Pkd2l1 (I), III-tubulin (J), Gata2 (K, GFP, Gata2GFP) or Sox2 (L), and the ependymocyte markers 
Foxj1 (M), Sox9 (N), Nfia (O), S100 (P) and Vimentin (Q). Sox2 labels both CSF-cNs and 
ependymocytes. In the controls, labeled cells express CSF-cN markers, while in Ascl1 KO mice they 
only express ependymal proteins (summarized in R).  
S-T) Electrophysiological recordings of labeled cells in control and Ascl1 KO acute slices. Whole cell 
voltage clamp recordings of currents evoked with depolarizing pulses (0mV, 40mV, 500ms, n=11-13 
cells). Inset: current-voltage plot of the peak inward fast and steady-state outward current in control 
mice. In Ascl1 KOs, Tomato+ cells exhibited the diverse responses described for ependymocytes. 
The percentages of cells matching each electrophysiological profile is indicated to the right.  T) I-V 
graph of the leakage currents determined in Tomato-labeled cells in control and Ascl1 mutant spinal 
cords. Tomato+ cells in the mutants exhibit robust leakage currents as described for mural ependymal 
cells. Data is mean±SEM.  
Scale bars are 5μm, except 40μm in B,C. 
  
 
Table S1. Oligonucleotides used for genotyping in this study. Related to STAR 
Methods and Key Resources Table 
 
oligo name oligo sequence source 
NeoF1 GCATACGCTTGATCCGGCTACC  this paper 
NeoR1 AAGGCGATGCGCTGCGAATC this paper 
EGFP1 GACGTAAACGGCCACAAGTT this paper 
EGFP2 GAACTCCAGCAGGACCATGT this paper 
td-Tomato Fw ACGGCATGGACGAGCTGTAC   this paper 
td-Tomato Rev CAGGCGAGCAGCCAAGGCAA this paper 
Cre3-Rv TAATCGCCATCTTCCAGCAG this paper 
CreJ-Fw GCGGTCTGGCAGTAAAAACTATC this paper 
Foxn4-1 GGCCTCTCTGTCCATACCTGTA this paper 
Foxn4-2 CTACTCTCTTTGATGACAGCTCCC  this paper 
lacz392 TTGGCGTAAGTGAAGCGAC this paper 
lacz393 AGCGGCTGATGTTGAACTG this paper 
Ascl1wt1 CTCCGGGAGCATGTCCCCAA  this paper 
Ascl1wt2 CCAGGACTCAATACGCAGGG  this paper 
Ascl1fl wtFw CTACTGTCCAAACGCAAAGTGG this paper 
Ascl1fl wtRev GCTCCCACAATCCTCGTAAAGA this paper 
Ascl1fl Rev TAGACGTTGTGGCTGTTGTAGT this paper 
 
 
 
